# Presepsin to Safely Reduce Antibiotics in Preterm Infants

> **NCT06100614** · NA · RECRUITING · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 900 (estimated)

## Conditions studied

- Early-Onset Neonatal Sepsis

## Interventions

- **DIAGNOSTIC_TEST:** Presepsin
- **DIAGNOSTIC_TEST:** Standard Care

## Key facts

- **NCT ID:** NCT06100614
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-23
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06100614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06100614, "Presepsin to Safely Reduce Antibiotics in Preterm Infants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06100614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*